Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer

Greenblatt, 1994, Mutations in the p53 tumor-suppressor gene: clues to cancer etiology and molecular pathogenesis, Cancer Res., 54, 4855 Taylor, 1996, p53 Mutations in bladder tumors from arylamine-exposed workers, Cancer Res., 55, 294 Martone, 1998, 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer, Int. J. Cancer, 75, 512, 10.1002/(SICI)1097-0215(19980209)75:4<512::AID-IJC4>3.0.CO;2-W Brockmöller, 1996, Polymorphic enzymes of xenobiotic metabolism as modulators of acquired p53 mutations in bladder cancer, Pharmacogenetics, 6, 535, 10.1097/00008571-199612000-00007 Esteve, 1995, Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors, J. Occup. Environ. Med., 37, 59, 10.1097/00043764-199501000-00009 Esrig, 1993, p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade and stage in bladder cancer, Am. J. Pathol., 143, 1389 Vet, 1994, p53 Mutations have no additional prognostic value over stage in bladder cancer, Br. Med. J., 70, 496 Coles, 1990, The role of glutathione and glutathione transferases in chemical carcinogenesis, Crit. Rev. Biochem. Mol. Biol., 25, 47, 10.3109/10409239009090605 Vineis, 1999, Metabolic polymorphisms and susceptibility to cancer in humans, IARC Sci. Publ., 145 Cascorbi, 1999, Arylamine N-acetyltransferase activity in man, Drug Metab. Rev., 31, 489, 10.1081/DMR-100101932 Minchin, 1992, N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells, Biochem. Biophys. Res. Commun., 185, 839, 10.1016/0006-291X(92)91703-S Zhu, 1998, Functional role of estrogen metabolism in target cells: review and perspectives, Carcinogenesis, 19, 1, 10.1093/carcin/19.1.1 Zhu, 1994, Catechol-O-methyltransferase-catalyzed rapid O-methylation of mutagenic flavonoids. Metabolic inactivation as a possible reason for their lack of carcinogenicity in vivo, J. Biol. Chem., 269, 292, 10.1016/S0021-9258(17)42348-9 Cavalieri, 1997, Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators, Proc. Natl. Acad. Sci., U.S.A., 94, 10937, 10.1073/pnas.94.20.10937 Malaveille, 1996, Dietary phenolics as anti-mutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers, Carcinogenesis, 17, 2193, 10.1093/carcin/17.10.2193 Syvanen, 1997, Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland, Pharmacogenetics, 7, 65, 10.1097/00008571-199702000-00009 Jaiswal, 1991, Human NAD(P)H: quinone oxidoreductase (NQO1) gene structure and induction by dioxin, Biochemistry, 30, 10647, 10.1021/bi00108a007 Cadenas, 1995, Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism, Biochem. Pharmacol., 49, 127, 10.1016/S0006-2952(94)00333-5 Traver, 1992, NAD(P)H: quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity, Cancer Res., 52, 797 Schulz, 1997, Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies, Pharmacogenetics, 7, 235, 10.1097/00008571-199706000-00008 Miller, 1994, Sulfonation in chemical carcinogenesis — history and present status, Chem. Biol. Interact., 92, 329, 10.1016/0009-2797(94)90074-4 Chou, 1995, Metabolic activation of the N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(S), Cancer Res., 55, 525 Hofstra, 1993, Myeloperoxidase-mediated activation of xenobiotics by human leukocytes, Toxicology, 82, 221, 10.1016/0300-483X(93)90066-2 Mallet, 1991, Activation of (±)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidase, Carcinogenesis, 12, 521, 10.1093/carcin/12.3.521 Kadlubar, 1992, Polymorphisms for aromatic amine metabolism in humans: revelance for human carcinogenesis, Environ. Health Perspect., 98, 69, 10.1289/ehp.929869 Bell, 1993, Genotype/phenotype discordance for human N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans, Carcinogenesis, 14, 1689, 10.1093/carcin/14.8.1689 Bartsch, 1998, Genetic polymorphisms of N-acetyltransferases, glutathione-S-transferase M1 and NAD(P)H: quinone oxidoreductase in relation to malignant and benign pancreatic disease risk, Eur. J. Cancer Prev., 7, 215, 10.1097/00008469-199806000-00006 Peluso, 1998, White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study, Cancer Epidemiol., Biomarkers Prev., 7, 341 Pemble, 1994, Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism, Biochem. J., 300, 271, 10.1042/bj3000271 Saarikoski, 1998, Combined effect of polymorphic GST genes on individual susceptibility to lung cancer, Int. J. Cancer, 77, 516, 10.1002/(SICI)1097-0215(19980812)77:4<516::AID-IJC7>3.0.CO;2-X Ozawa, 1998, Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines, Chem.-Biol. Interact., 109, 237, 10.1016/S0009-2797(97)00135-X Hoda, 1996, No association between Parkinson's disease and low-activity alleles of catechol-O-methyl-transferase, Biochem. Biophys. Res. Commun., 21, 780, 10.1006/bbrc.1996.1731 T.J. Monks, S.S. Lau, Glutathione conjugate mediated toxicities, in: F.C. Kauffman (Ed.), Handbook of Experimental Pharmacology: Conjugation–Deconjugation Reactions in Drug Metabolism and Toxicity, Vol. 112, Springer-Verlag, New York, 1999, pp. 459–509. Atsmon, 1990, Conjugation of 9-deoxy-Δ9,Δ12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion, Cancer Res., 50, 1879 Sato, 1990, Antiproliferative effects of glutathione S-transferase inhibitors on the K562 cell line, Biochem. Pharmacol., 39, 1263, 10.1016/0006-2952(90)90273-N Bogaards, 1997, Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalzyed by the human glutathione S-transferases A1-1, A2-2, M1a-1a and P1-1, Res. Toxicol., 10, 310, 10.1021/tx9601770 Lombardi, 1981, Enzymatic methylation of microsomal metabolites of benzo(a)pyrene, Cancer Res., 41, 4415